Association of B cells in tumor microenvironment (TME) with clinical benefit to programmed cell death protein-1 (PD-1) blockade therapy in esophageal squamous cell carcinoma (ESCC).

被引：2
|
作者：
Guo, Jhe-Cyuan [1 ]
Hsu, Chia-Lang [2 ]
Huang, Yen-Lin [3 ]
Lin, Chia-Chi [3 ]
Huang, Ta-Chen [3 ]
Chang, Chun-Jung [4 ]
Kuo, Hung-Yang [5 ]
Hsu, Chih-Hung [1 ]
机构：
[1] Natl Taiwan Univ, Ctr Canc, Taipei, Taiwan
[2] Natl Taiwan Univ Hosp, Dept Med Res, Taipei, Taiwan
[3] Natl Taiwan Univ Hosp, Taipei, Taiwan
[4] Natl Taiwan Univ Hosp, Dept Oncol, Taipei, Taiwan
[5] Natl Taiwan Univ Hosp, Taipei, Taiwan
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2021年 / 39卷 / 03期
关键词：
D O I：
10.1200/JCO.2021.39.3_suppl.237
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
237
引用
收藏
页数：2
相关论文
共 50 条
  • [31] Enhanced programmed death 1 (PD-1) and PD-1 ligand (PD-L1) expression in patients with actinic cheilitis and oral squamous cell carcinoma
    Tatiana Salles de Souza Malaspina
    Thaís Helena Gasparoto
    Maria Renata Sales Nogueira Costa
    Edgard Franco de Melo
    Maura Rosane Valério Ikoma
    José Humberto Damante
    Karen Angélica Cavassani
    Gustavo Pompermaier Garlet
    João Santana da Silva
    Ana Paula Campanelli
    Cancer Immunology, Immunotherapy, 2011, 60 : 965 - 974
  • [32] Clinical significance of programmed death-1 and programmed death-ligand 1 expression in the tumor microenvironment of clear cell renal cell carcinoma
    Mikami, Shuji
    Mizuno, Ryuichi
    Kondo, Tsunenori
    Shinohara, Nobuo
    Nonomura, Norio
    Ozono, Seiichiro
    Eto, Masatoshi
    Tatsugami, Katsunori
    Takayama, Tatsuya
    Matsuyama, Hideyasu
    Kishida, Takeshi
    Oya, Mototsugu
    CANCER SCIENCE, 2019, 110 (06) : 1820 - 1828
  • [33] Enhanced programmed death 1 (PD-1) and PD-1 ligand (PD-L1) expression in patients with actinic cheilitis and oral squamous cell carcinoma
    de Souza Malaspina, Tatiana Salles
    Gasparoto, Thais Helena
    Sales Nogueira Costa, Maria Renata
    de Melo, Edgard Franco, Jr.
    Valerio Ikoma, Maura Rosane
    Damante, Jose Humberto
    Cavassani, Karen Angelica
    Garlet, Gustavo Pompermaier
    da Silva, Joao Santana
    Campanelli, Ana Paula
    CANCER IMMUNOLOGY IMMUNOTHERAPY, 2011, 60 (07) : 965 - 974
  • [34] Clinical Significance of Programmed Death Ligand-1 Expression in Esophageal Squamous Cell Carcinoma
    Ito, Nozomi
    Tsujimoto, Hironori
    Horiguchi, Hiroyuki
    Shimazaki, Hideyuki
    Miyazaki, Hiromi
    Saitoh, Daizoh
    Kishi, Yoji
    Ueno, Hideki
    JOURNAL OF SURGICAL RESEARCH, 2020, 251 : 321 - 328
  • [35] Neoadjuvant PD-1 blockade combined with chemotherapy for patients with resectable locally advanced esophageal squamous cell carcinoma (ESCC): A real world data analysis
    Lv, H.
    Tian, Y.
    Huang, C.
    Sun, B.
    Gai, C.
    Li, Z.
    Tian, Z.
    ANNALS OF ONCOLOGY, 2021, 32 : S1423 - S1423
  • [36] Programmed Cell Death 1 (PD-1) Is Over Expressed in Giant Cell Tumor of the Bone and Adamantinoma
    Torabi, Alireza
    Bryan, Brad A.
    Amaya, Clarissa N.
    Wians, Frank H.
    MODERN PATHOLOGY, 2017, 30 : 26A - 26A
  • [37] Prior irradiation results in elevated programmed cell death protein 1 (PD-1) in T cells
    Li, Deguan
    Chen, Renxiang
    Wang, Yi-Wen
    Fornace, Albert J., Jr.
    Li, Heng-Hong
    INTERNATIONAL JOURNAL OF RADIATION BIOLOGY, 2018, 94 (05) : 488 - 494
  • [38] Evaluation of programmed cell death protein 1 (PD-1) expression as a prognostic biomarker in patients with clear cell renal cell carcinoma
    Kim, Kyu Seo
    Sekar, Rishi R.
    Patil, Dattatraya
    Dimarco, Michelle A.
    Kissick, Haydn T.
    Bilen, Mehmet A.
    Osunkoya, Adeboye O.
    Master, Viraj A.
    ONCOIMMUNOLOGY, 2018, 7 (04):
  • [39] Programmed Cell Death 1 (PD-1) Is Over Expressed in Giant Cell Tumor of the Bone and Adamantinoma
    Tombi, Alireza
    Bryan, Brad A.
    Amaya, Clarissa N.
    Wians, Frank H.
    LABORATORY INVESTIGATION, 2017, 97 : 26A - 26A
  • [40] Programmed Cell Death Protein 1 (PD-1) and Programmed Cell Death Ligand 1 (PD-L1) Immunotherapy: A Promising Breakthrough in Cancer Therapeutics
    Abaza, Abdelrahman
    Idris, Faten Sid
    Shaikh, Humna Anis
    Vahora, Ilma
    Moparthi, Kiran Prasad
    Al Rushaidi, Majdah T.
    Muddam, Meghana Reddy
    Obajeun, Omobolanle A.
    Jaramillo, Arturo P.
    Khan, Safeera
    CUREUS JOURNAL OF MEDICAL SCIENCE, 2023, 15 (09)
12345